Abstract 2647: Novel FGFR2 biparatopic antibodies for the treatment of cholangiocarcinoma
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-2647
Abstract: Translocations involving Fibroblast Growth Factor Receptor 2 (FGFR2) are found in up to 45% of Intrahepatic Cholangiocarcinoma (ICC). Treatment of patients bearing FGFR2 fusions with FGFR kinase inhibitors induces tumor regressions, though response rate and… read more here.
Keywords: fusion; fgfr2; growth; biparatopic antibodies ... See more keywords